Novel vaccine technologies for the 21st century

Nature Reviews Immunology
Volume 20 Issue 2, February 2020


Year in Review | 11 November 2019
Novel vaccine technologies for the 21st century
New approaches to vaccine development have generated exciting results over the past 18 months. Focusing on respiratory syncytial virus infection, influenza and tuberculosis, Fauci and Mascola discuss the impact of structure-based vaccine design, gene-based vaccine platforms and advances in adjuvant development.
John R. Mascola  & Anthony S. Fauci